User profiles for Mansour Tobaiqy

Mansour Tobaiqy

Assoc. Prof. of Pharmacology College of Medicine, University of Jeddah, Visiting Professor
Verified email at uj.edu.sa
Cited by 1080

[HTML][HTML] Therapeutic management of patients with COVID-19: a systematic review

M Tobaiqy, M Qashqary, S Al-Dahery… - Infection Prevention in …, 2020 - Elsevier
Background Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the causative
agent of coronavirus disease 2019 (COVID-19), which was declared a global pandemic …

[HTML][HTML] Optimizing use of theranostic nanoparticles as a life-saving strategy for treating COVID-19 patients

R Itani, M Tobaiqy, A Al Faraj - Theranostics, 2020 - ncbi.nlm.nih.gov
On the 30 th of January 2020, the World Health Organization fired up the sirens against a
fast spreading infectious disease caused by a newly discovered Severe Acute Respiratory …

[HTML][HTML] Analysis of thrombotic adverse reactions of COVID-19 AstraZeneca vaccine reported to EudraVigilance database

M Tobaiqy, H Elkout, K MacLure - Vaccines, 2021 - mdpi.com
The development of safe, effective, affordable vaccines against COVID-19 remains the
cornerstone to mitigating this pandemic. Early in December 2020, multiple research groups had …

Foundation year 1 doctors and clinical pharmacology and therapeutics teaching. A retrospective view in light of experience

M Tobaiqy, J McLay, S Ross - British journal of clinical …, 2007 - Wiley Online Library
… A retrospective view in light of experience - Tobaiqy - 2007 - British Journal of Clinical
Pharmacology - Wiley Online Library … Mansour TobaiqyMansour Tobaiqy

[HTML][HTML] Thrombotic adverse events reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 vaccines: comparison of occurrence and clinical outcomes in the …

M Tobaiqy, K MacLure, H Elkout, D Stewart - Vaccines, 2021 - mdpi.com
Vaccination against COVID-19 is the cornerstone of controlling and mitigating the ongoing
pandemic. Thrombotic adverse events linked to Moderna, Pfizer and the Oxford-AstraZeneca …

[HTML][HTML] Efficacy and safety of lopinavir/ritonavir for treatment of COVID-19: a systematic review and meta-analysis

…, Z Al Alawi, N Alhmeed, ARZ Zaidi, M Tobaiqy - Tropical medicine and …, 2020 - mdpi.com
(Background) Lopinavir-ritonavir (LPV/RTV) is a human immunodeficiency virus (HIV) antiviral
combination that has been considered for the treatment of COVID-19 disease. (Aim) This …

[HTML][HTML] Antimicrobial susceptibility of gram-positive and gram-negative bacteria: a 5-year retrospective analysis at a multi-hospital healthcare system in Saudi Arabia

…, Z Al Alawi, AJ Alzahrani, M Tobaiqy… - Annals of clinical …, 2021 - Springer
Background Studying time-related changes in susceptible pathogens causing healthcare-associated
infections (HAIs) is vital in improving local antimicrobial and infection control …

[HTML][HTML] Frequency and management of acute poisoning among children attending an emergency department in Saudi Arabia

M Tobaiqy, BA Asiri, AH Sholan, YA Alzahrani… - Pharmacy, 2020 - mdpi.com
Background: Acute poisoning is one of the common medical emergencies in children that
leads to morbidity and mortality. Medications and chemical agents play a major role in these …

[HTML][HTML] Assessment of preventative measures practice among Umrah pilgrims in Saudi Arabia, 1440H-2019

M Tobaiqy, AH Alhasan, MM Shams, SA Amer… - International Journal of …, 2021 - mdpi.com
Background: Annually, approximately 10 million pilgrims travel to the Kingdom of Saudi Arabia
(KSA) for Umrah from more than 180 countries. This event presents major challenges for …

Exploring health professionals' experiences of medication errors in Saudi Arabia

M Tobaiqy, D Stewart - International journal of clinical pharmacy, 2013 - Springer
Background There is a paucity of literature originating from the Middle East on medication
errors. Objective To explore the experiences of healthcare professionals around medication …